SMARTER SCREENINGS: The U.S. Food and Drug Administration (FDA) has approved the first artificial intelligence (AI) tool to predict breast cancer risk. 'WE WILL FIGHT': OpenAI CEO Sam Altman said ...

FDA employees report the agency's new AI assistant produces incorrect answers and lacks essential safeguards. (Shutterstock) ...

AI therapy apps promise easy access to mental health care. But convenience comes with hidden costs we're only just beginning ...

The E4S Project announced the availability of Release 25.06 that includes new features, including an expanded AI portfolio ...

The FDA is using Elsa to accelerate clinical protocol reviews, shorten the time needed for scientific evaluations and identify high-priority inspection targets.

There are problems with generative AI, and there need to be guardrails and there needs to be human oversight," said Jason ...

Over the past year, advancements in artificial intelligence (AI) and predictive analytics have rapidly revolutionized the ...

Neil Young once sang of adapting to a world ruled by data and digital minds in “Computer Age.” Today, that vision feels increasingly real as the ...

Over the past year, drug discovery has gotten a massive boost from the CAS BioFinder Discovery Platform, which allows ...

The Food and Drug Administration has officially launched "Elsa," a generative artificial intelligence platform designed to ...

While clinical applications exist, radiologists are using AI to increase productivity, and to help them communicate ...

AI has remarkable potential to enhance psychological well-being, expand cognitive capabilities, and facilitate human flourishing. Harnessing this requires deliberate approaches.